Aman Chauhan/X
May 31, 2025, 07:33
Aman Chauhan Shared Updates on SVV-Ipi-Nivo Trial Enrollment and Patient Support at Sylvester Comprehensive Cancer Center
Aman Chauhan, Leader of Neuroendocrine Cancer Program at the Sylvester Comprehensive Cancer Center, shared a post X:
“What a day! We consented two patients to our SVV-Ipi-Nivo study (NCT06889493) for high-grade neuroendocrine cancer-closing Cohort 1 in under a month! To add to the momentum, we received incredible news of a generous philanthropic gift from the Nichole Borchard Foundation to support travel expenses for patients journeying long distances to join this trial. A true testament to the power of collaboration between academia, industry, and patient advocacy.
Also had the privilege of showcasing our Theranostics facility to our Commander-in-Chief, Stephen D. Nimer. In just two years, we’ve gone from providing standard-of-care therapies to enrolling patients in cutting-edge, first-in-human theranostic trials. Immensely grateful to the leadership at Sylvester Comprehensive Cancer Center for championing this vision.
Off to Chicago now! ASCO here I come”
More posts featuring Aman Chauhan on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 31, 2025, 07:32
May 31, 2025, 07:20
May 31, 2025, 07:14
May 31, 2025, 06:50
May 31, 2025, 06:42
May 31, 2025, 05:11